Staff Members - Benha University
Arginine dimethylation products in pediatric patients with chronic kidney disease
• 2016
Publication Information
Authors
Akram E. El-Sadek a, *, Eman G. Behery b, Ahmed A. Azab a, Naglaa M. Kamal c,
Mostafa A. Salama a, Waleed E. Abdulghany a, Enas A.A. Abdallah c
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: arginine and its metabolites have been linked to pediatric chronic kidney disease (CKD).We
aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric
dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney function.
Patients and methods: 132 pediatric patients with CKD and 120 healthy age and sex matched controls
were compared regarding; serum Arg, ADMA and SDMA levels.
Results: In comparison to their values in control subjects, serum Arg levels were significantly lower;
serum ADMA levels were non-significantly higher, but serum SDMA levels were significantly higher in
CKD patients (p values: < 0.000; ¼ 0.054;
aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric
dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney function.
Patients and methods: 132 pediatric patients with CKD and 120 healthy age and sex matched controls
were compared regarding; serum Arg, ADMA and SDMA levels.
Results: In comparison to their values in control subjects, serum Arg levels were significantly lower;
serum ADMA levels were non-significantly higher, but serum SDMA levels were significantly higher in
CKD patients (p values: < 0.000; ¼ 0.054;